These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21218277)

  • 21. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers.
    Coetzee B; Kagee A; Vermeulen N
    AIDS Care; 2011 Feb; 23(2):146-51. PubMed ID: 21259126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M
    HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda.
    Senkomago V; Guwatudde D; Breda M; Khoshnood K
    AIDS Care; 2011 Oct; 23(10):1246-53. PubMed ID: 21939403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concerns about stigma, social support and quality of life in low-income HIV-positive Hispanics.
    Larios SE; Davis JN; Gallo LC; Heinrich J; Talavera G
    Ethn Dis; 2009; 19(1):65-70. PubMed ID: 19341165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries.
    Etienne M; Hossain M; Redfield R; Stafford K; Amoroso A
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):98-103. PubMed ID: 20207981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
    BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "I want to stand on my own legs": A qualitative study of antiretroviral therapy adherence among HIV-positive women in Egypt.
    Badahdah AM; Pedersen DE
    AIDS Care; 2011 Jun; 23(6):700-4. PubMed ID: 21476148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression in the pathway of HIV antiretroviral effects on sexual risk behavior among patients in Uganda.
    Wagner GJ; Ghosh-Dastidar B; Holloway IW; Kityo C; Mugyenyi P
    AIDS Behav; 2012 Oct; 16(7):1862-9. PubMed ID: 21986868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
    Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
    J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in Kwazulu-Natal, South Africa.
    Peltzer K; Friend-du Preez N; Ramlagan S; Fomundam H; Anderson J
    Afr J Tradit Complement Altern Med; 2009 Dec; 7(2):125-37. PubMed ID: 21304624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV and tuberculosis in Durban, South Africa: adherence to two medication regimens.
    Corless IB; Wantland D; Bhengu B; McInerney P; Ncama B; Nicholas PK; McGibbon C; Wong E; Davis SM
    AIDS Care; 2009 Sep; 21(9):1106-13. PubMed ID: 20024769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya.
    Talam NC; Gatongi P; Rotich J; Kimaiyo S
    East Afr J Public Health; 2008 Aug; 5(2):74-8. PubMed ID: 19024414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Depressive symptoms in people living with HIV: related factors].
    Yeh ML; Hsu ST; Ko WC; Ko NY
    Hu Li Za Zhi; 2012 Apr; 59(2):40-50. PubMed ID: 22469891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antiretroviral therapy in Taiwan.
    Yen CF; Tsai JJ; Lu PL; Chen YH; Chen TC; Chen PP; Chen TP
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):501-6. PubMed ID: 15482581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa.
    Ncama BP; McInerney PA; Bhengu BR; Corless IB; Wantland DJ; Nicholas PK; McGibbon CA; Davis SM
    Int J Nurs Stud; 2008 Dec; 45(12):1757-63. PubMed ID: 18653188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life of HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa.
    Mekuria LA; Sprangers MA; Prins JM; Yalew AW; Nieuwkerk PT
    AIDS Care; 2015; 27(8):934-45. PubMed ID: 25782603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
    Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
    AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.